Investigating how HIV affects the development of classic Hodgkin lymphoma
Understanding the pathogenesis of classic Hodgkin lymphoma in persons living with HIV through conventional and spatial transcriptomics
This study is looking at why people with HIV might have a higher chance of developing classic Hodgkin lymphoma, and it aims to understand the differences in their immune system and genes that could lead to this cancer, with the help of patient samples.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10954155 on NIH RePORTER |
What this research studies
This research explores the increased risk of classic Hodgkin lymphoma (CHL) in individuals living with HIV. It focuses on understanding the unique immune environment and genetic changes in these patients that may contribute to the development of this type of cancer. By utilizing advanced techniques like spatial transcriptomics, the study aims to uncover the underlying mechanisms that differentiate CHL in HIV-positive patients from those in the general population. Patients may be involved in providing samples to help researchers analyze these differences.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who are at risk of developing classic Hodgkin lymphoma.
Not a fit: Patients who do not have HIV or those who have already been diagnosed and treated for classic Hodgkin lymphoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for classic Hodgkin lymphoma in patients living with HIV.
How similar studies have performed: Previous studies have indicated that understanding the immune microenvironment can significantly impact cancer treatment, suggesting that this approach may yield valuable insights.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Naresh, Kikkeri — Fred Hutchinson Cancer Center
- Study coordinator: Naresh, Kikkeri
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.